Africa CDC and the Ethiopian Ministry of Health are integrating the Marburg response with mpox preparedness and surveillance to optimize resources, speed up detection, and curb regional spread.

The initial alert of a suspected viral hemorrhagic fever was issued on November 12, 2025, with laboratory confirmation of Marburg virus disease (MVD) on November 14, 2025.

Core genomics facilities at EPHI and AHRI have been enhanced through Africa CDC and partners, enabling rapid laboratory confirmation and stronger outbreak readiness through genome sequencing and diagnostics.

Africa CDC commits to providing further updates as more information becomes available.

This effort fits within a broader regional preparedness and response framework for emerging infectious diseases, built through collaboration with EPHI, AHRI, and other partners.

Africa CDC confirms the Marburg outbreak in Jinka, Southern Region, Ethiopia, based on confirmation from the Federal Ministry of Health and the Ethiopian Public Health Institute as of November 14, 2025.

Africa CDC has strengthened Ethiopia’s molecular diagnostics and genomic surveillance by supplying sequencing equipment, reagents, Marburg-specific PCR assays, and extensive lab training.

Africa CDC Director-General plans to meet with Ethiopia’s Minister of Health to assess additional support needs and reinforce cross-border readiness with neighboring countries.

Ethiopian authorities have activated response measures, including enhanced surveillance, field investigations, strengthened infection prevention and control, and community engagement.

AHRI’s capacity has been expanded to serve as a central player in the Marburg outbreak response, with ongoing support for equipment, reagents, and targeted training.